Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Works (26)

Population Pharmacokinetics of Cobicistat and its Effect on the Pharmacokinetics of the Anticancer Drug Olaparib

Clinical Pharmacokinetics
2025-02-05 | Journal article
DOI: 10.1007/s40262-025-01480-w
Contributors: Joanneke K. Overbeek; Nielka P. van Erp; David M. Burger; Alfons A. den Broeder; Stijn L. W. Koolen; Alwin D. R. Huitema; Rob ter Heine
Source: check_circle
Crossref

Trial Versus Real-World Circumstances and How to Interpret Pharmacokinetic Data

Clinical Infectious Diseases
2024-12-30 | Journal article
DOI: 10.1093/cid/ciae636
Contributors: Lena van der Wekken-Pas; Fabian Weiss; Charlotte Simon-Zuber; Rena Sebisch; Carmen Wiese; Liesbeth van Leeuwen; David Burger; Angela Colbers
Source: check_circle
Crossref

Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians

Clinical Pharmacokinetics
2024-11 | Journal article
DOI: 10.1007/s40262-024-01437-5
Contributors: David M. Burger; Laura Nijboer; Mira Ghobreyal; Johan Maertens; Nicole Blijlevens; Luuk Hilbrands; Marije C. Baas; Per Ljungman; Roger J. M. Brüggemann
Source: check_circle
Crossref

Patients in Clinical Trials are Sub‐Optimally Protected for Drug–Drug Interactions: A Call for Action

The Journal of Clinical Pharmacology
2024-11-21 | Journal article
DOI: 10.1002/jcph.6168
Contributors: David Burger; Loek de Jong; Daphne van Dijk; Catherijne A. J. Knibbe; Rob ter Heine; Elise Smolders; Munir Pirmohamed
Source: check_circle
Crossref

Availability and stock‐outs of paediatric antiretroviral treatment formulations at health facilities in Kenya and Uganda

HIV Medicine
2024-07 | Journal article
DOI: 10.1111/hiv.13635
Contributors: Tom G. Jacobs; Dorothy Okemo; Anthony Ssebagereka; Kenneth Mwehonge; Emily M. Njuguna; David M. Burger; Angela Colbers; Fatima Suleman; Aukje K. Mantel‐Teeuwisse; Gaby I. Ooms
Source: check_circle
Crossref

Interchangeability of generic drugs for subpopulations: Bioequivalence simulation from a nonparametric PK model of gabapentin generic drugs

British Journal of Clinical Pharmacology
2024-07 | Journal article
DOI: 10.1111/bcp.15629
Contributors: Pieter J. Glerum; Walter M. Yamada; Michael N. Neely; David M. Burger; Marc Maliepaard; Cees Neef
Source: check_circle
Crossref

CHAPAS-4 trial: second-line anchor drugs for children with HIV in Africa

2024-04-15 | Preprint
DOI: 10.1101/2024.04.12.24305333
Contributors: Mutsa Bwakura-Dangarembizi; Alexander J Szubert; Vivian Mumbiro; Cissy M Kityo; Abbas Lugemwa; Katja Doerholt; Chishala Chabala; Mary Nyathi; Bwendo Nduna; David Burger et al.
Source: check_circle
Crossref

GLP‐1 agonists for people living with HIV and obesity, is there a potential?

HIV Medicine
2023-10 | Journal article
DOI: 10.1111/hiv.13521
Contributors: L. Zino; C. J. Tack; O. Richel; D. M. Burger
Source: check_circle
Crossref

Potential drug–drug interactions in males living with HIV who use drugs to treat lower urinary tract symptoms

HIV Medicine
2023-10 | Journal article
DOI: 10.1111/hiv.13519
Contributors: David Burger; Piter Oosterhof; Karin Grintjes; Manon Marneef‐Pietersma; Frank d'Ancona; Xiaoye Zhu; Stephan Keijmel; Olivier Richel; Reinout van Crevel; David Jansen
Source: check_circle
Crossref

What the product label does not tell you about drug‐drug interaction management time for a re‐appraisal

The Journal of Clinical Pharmacology
2023-07-21 | Journal article
DOI: 10.1002/jcph.2316
Contributors: David M Burger; Marianne le Comte; Elise J Smolders; Tom Jacobs; Rob ter Heine; Catherijne Knibbe; Munir Pirmohamed
Source: check_circle
Crossref

Sustained virological response in an HCV-infected patient on an enzyme-inducing anti-epileptic agent despite undetectable trough plasma levels of velpatasvir

Journal of Hepatology
2023-05 | Journal article
DOI: 10.1016/j.jhep.2023.01.015
Contributors: David Burger; Huseyin Aktas; Robert de Knegt
Source: check_circle
Crossref

Abacavir pharmacokinetics in African children living with HIV: A pooled analysis describing the effects of age, malnutrition and common concomitant medications

British Journal of Clinical Pharmacology
2022-02 | Journal article
DOI: 10.1111/bcp.14984
Contributors: Tjokosela Tikiso; Helen McIlleron; David Burger; Diana Gibb; Helena Rabie; Janice Lee; Marc Lallemant; Mark F. Cotton; Moherndran Archary; Stefanie Hennig et al.
Source: check_circle
Crossref

The potential of individualized dosing of ravulizumab to improve patient‐friendliness of paroxysmal nocturnal haemoglobinuria treatment at reduced costs

British Journal of Clinical Pharmacology
2021-08 | Journal article
DOI: 10.1111/bcp.14748
Contributors: Mendy ter Avest; Saskia M.C. Langemeijer; Saskia E.M. Schols; David M. Burger; Nicole C.A.J. van de Kar; Nicole M.A. Blijlevens; Wietske Kievit; Rob ter Heine
Source: check_circle
Crossref

Association between healthcare practitioners' beliefs about statins and patients' beliefs and adherence

British Journal of Clinical Pharmacology
2021-03 | Journal article
DOI: 10.1111/bcp.14467
Contributors: Victor J.B. Huiskes; Cornelia H.M. van den Ende; Liset van Dijk; David M. Burger; Bartholomeus J.F. van den Bemt
Source: check_circle
Crossref

COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions

British Journal of Clinical Pharmacology
2021-01 | Journal article
DOI: 10.1111/bcp.14358
Contributors: David Back; Catia Marzolini; Catherine Hodge; Fiona Marra; Alison Boyle; Sara Gibbons; David Burger; Saye Khoo
Source: check_circle
Crossref

Cobicistat: A case of mislabelled drug‐drug interaction risk?

British Journal of Clinical Pharmacology
2020-05 | Journal article
DOI: 10.1111/bcp.14262
Contributors: David M. Burger; Alexandra Calmy; Catia Marzolini
Source: check_circle
Crossref

Effectiveness of medication review on the number of drug‐related problems in patients visiting the outpatient cardiology clinic: A randomized controlled trial

British Journal of Clinical Pharmacology
2020-01 | Journal article
DOI: 10.1111/bcp.14125
Contributors: Victor Johan Bernard Huiskes; Cornelia Helena Maria van den Ende; Martine Kruijtbosch; Hendrik Tinus Ensing; Marieke Meijs; Veronique Maria Mathea Meijs; David Marinus Burger; Bartholomeus Johannes Fredericus van den Bemt
Source: check_circle
Crossref

Review article: direct‐acting antivirals for the treatment of HCV during pregnancy and lactation ‐ implications for maternal dosing, foetal exposure, and safety for mother and child

Alimentary Pharmacology & Therapeutics
2019-10 | Journal article
DOI: 10.1111/apt.15476
Contributors: Jolien J. M. Freriksen; Minou van Seyen; Ali Judd; Diana M. Gibb; Intira J. Collins; Rick Greupink; Frans G. M. Russel; Joost P. H. Drenth; Angela Colbers; David M. Burger
Source: check_circle
Crossref

Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update

Clinical Pharmacokinetics
2019-10 | Journal article
DOI: 10.1007/s40262-019-00774-0
Contributors: Elise J. Smolders; Anouk M. E. Jansen; Peter G. J. ter Horst; Jürgen Rockstroh; David J. Back; David M. Burger
Source: check_circle
Crossref

Safe use of proton pump inhibitors in patients with cirrhosis

British Journal of Clinical Pharmacology
2018-08 | Journal article
DOI: 10.1111/bcp.13615
Contributors: Rianne A. Weersink; Margriet Bouma; David M. Burger; Joost P.H. Drenth; S. Froukje Harkes‐Idzinga; Nicole G.M. Hunfeld; Herold J. Metselaar; Margje H. Monster‐Simons; Sandra A.W. van Putten; Katja Taxis et al.
Source: check_circle
Crossref

A pharmacological rationale for improved everolimus dosing in oncology and transplant patients

British Journal of Clinical Pharmacology
2018-07 | Journal article
DOI: 10.1111/bcp.13591
Contributors: R. ter Heine; N. P. van Erp; H. J. Guchelaar; J. W. de Fijter; M. E. J. Reinders; C. M. van Herpen; D. M. Burger; D. J. A. R. Moes
Source: check_circle
Crossref

Large differences in neonatal drug use between NICUs are common practice: time for consensus?

British Journal of Clinical Pharmacology
2018-06 | Journal article
DOI: 10.1111/bcp.13563
Contributors: Robert B. Flint; Floor van Beek; Peter Andriessen; Luc J. Zimmermann; Kian D. Liem; Irwin K.M. Reiss; Ronald de Groot; Dick Tibboel; David M. Burger; Sinno H.P. Simons
Source: check_circle
Crossref

Urinalysis of MMX‐mesalazine as a tool to monitor 5‐ASA adherence in daily IBD practice

British Journal of Clinical Pharmacology
2018-03 | Journal article
DOI: 10.1111/bcp.13462
Contributors: Tessa E. H. Römkens; Rene te Morsche; Wilbert Peters; David M. Burger; Frank Hoentjen; Joost P. H. Drenth
Source: check_circle
Crossref

Parenteral bilirubin in healthy volunteers: a reintroduction in translational research

British Journal of Clinical Pharmacology
2018-02 | Journal article
DOI: 10.1111/bcp.13458
Contributors: Douwe Dekker; Mirrin J. Dorresteijn; Marieke E. B. Welzen; Simone Timman; Peter Pickkers; David M. Burger; Paul Smits; Frank A. D. T. G. Wagener; Frans G. M. Russel
Source: check_circle
Crossref

Drug–drug interaction potential in men treated with enzalutamide: Mind the gap

British Journal of Clinical Pharmacology
2018-01 | Journal article
DOI: 10.1111/bcp.13425
Contributors: Guillemette Emma Benoist; Inge M. van Oort; Stella Smeenk; Adrian Javad; Diederik M. Somford; David M. Burger; Niven Mehra; Nielka P. van Erp
Source: check_circle
Crossref

In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir

British Journal of Clinical Pharmacology
2017-12 | Journal article
DOI: 10.1111/bcp.13396
Contributors: Diane E. T. Bastiaans; Laura I. Immohr; Gertrude G. Zeinstra; Riet Strik‐Albers; Miriam Pein‐Hackelbusch; Michiel van der Flier; Anton F. J. de Haan; Jaap Jan Boelens; Arjan C. Lankester; David M. Burger et al.
Source: check_circle
Crossref

Peer review (4 reviews for 4 publications/grants)

Review activity for Clinical pharmacokinetics (1)
Review activity for EJHP Practice. (1)
Review activity for Journal of infectious diseases. (1)
Review activity for The lancet. (1)
How many people are using ORCID?